{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:57:07Z","timestamp":1787021827002,"version":"build-2736575974"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011099","name":"deutsche gesellschaft f\u00fcr internationale zusammenarbeit","doi-asserted-by":"publisher","award":["PN77.2210"],"award-info":[{"award-number":["PN77.2210"]}],"id":[{"id":"10.13039\/501100011099","id-type":"DOI","asserted-by":"publisher"}]},{"name":"who\/tdr","award":["ID890067 and ID930543"],"award-info":[{"award-number":["ID890067 and ID930543"]}]},{"DOI":"10.13039\/100008077","name":"edna mcconnell clark foundation","doi-asserted-by":"publisher","award":["Grant 13694"],"award-info":[{"award-number":["Grant 13694"]}],"id":[{"id":"10.13039\/100008077","id-type":"DOI","asserted-by":"publisher"}]},{"name":"commission of the european community","award":["STD 3\/0178, Contract No TS3-CT92-0057, INCO DEV SCOOTT Contract No 032321, FP7 Project Grant Acronym E-PIAF #242131"],"award-info":[{"award-number":["STD 3\/0178, Contract No TS3-CT92-0057, INCO DEV SCOOTT Contract No 032321, FP7 Project Grant Acronym E-PIAF #242131"]}]},{"name":"DFG","award":["Kn244\/3-1, Di308\/12-1 and So367\/1-2"],"award-info":[{"award-number":["Kn244\/3-1, Di308\/12-1 and So367\/1-2"]}]},{"DOI":"10.13039\/501100002347","name":"bundesministerium f\u00fcr bildung und forschung","doi-asserted-by":"publisher","award":["grant 01KA1008 and 01DG20021"],"award-info":[{"award-number":["grant 01KA1008 and 01DG20021"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009397","name":"medizinischen fakult\u00e4t, eberhard karls universit\u00e4t t\u00fcbingen","doi-asserted-by":"publisher","award":["University Clinics T\u00fcbingen (UKT) Molecular Medicine Programme"],"award-info":[{"award-number":["University Clinics T\u00fcbingen (UKT) Molecular Medicine Programme"]}],"id":[{"id":"10.13039\/501100009397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Annual mass drug administrations (MDA) of ivermectin will strongly reduce\n                      <jats:italic>Onchocerca volvulus<\/jats:italic>\n                      microfilariae (mf) in the skin and in the onchocerciasis patients\u2019 eyes. Ivermectin treatment will also affect the expression of immunity in patients, such that activated immune defenses may help control and contribute to clearance of mf of\n                      <jats:italic>O<\/jats:italic>\n                      .\n                      <jats:italic>volvulus<\/jats:italic>\n                      . Longitudinal surveys are a prerequisite to determining the impact of ivermectin on the status of anti-parasite immunity, notably in risk zones where parasite transmission and active\n                      <jats:italic>O<\/jats:italic>\n                      .\n                      <jats:italic>volvulus<\/jats:italic>\n                      infections persist.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methodology\/Principal findings<\/jats:title>\n                    <jats:p>\n                      Onchocerciasis patients were treated annually with ivermectin and their\n                      <jats:italic>Onchocerca volvulus<\/jats:italic>\n                      antigen (OvAg) specific IgG and cellular responses were investigated before and at 30 years post initial ivermectin treatment (30yPT).\n                    <\/jats:p>\n                    <jats:p>\n                      Repeated annual ivermectin treatments eliminated persisting\n                      <jats:italic>O<\/jats:italic>\n                      .\n                      <jats:italic>volvulus<\/jats:italic>\n                      microfilariae (mf) from the skin of patients and abrogated patent infections. The OvAg-specific IgG1 and IgG4 responses were diminished at 30yPT to the levels observed in endemic controls. Prior to starting ivermectin treatment, OvAg-induced cellular productions of IL-10, IFN-\u03b3, CCL13, CCL17 and CCL18 were low in patients, and at 30yPT, cellular cytokine and chemokine responses increased to the levels observed in endemic controls. In contrast, mitogen(PHA)- induced IL-10, IFN-\u03b3, CCL17 and CCL18 cellular production was diminished. This divergent response profile thus revealed increased parasite antigen-specific but reduced polyclonal cellular responsiveness in patients. The transmission of\n                      <jats:italic>O<\/jats:italic>\n                      .\n                      <jats:italic>volvulus<\/jats:italic>\n                      continued at the patients\u2019 location in the M\u00f4 river basin in central Togo 2018 and 2019 when 0.58% and 0.45%, respectively, of\n                      <jats:italic>Simulium damnosum s<\/jats:italic>\n                      .\n                      <jats:italic>l<\/jats:italic>\n                      . vector blackflies carried\n                      <jats:italic>O<\/jats:italic>\n                      .\n                      <jats:italic>volvulus<\/jats:italic>\n                      infections.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions\/Significance<\/jats:title>\n                    <jats:p>\n                      Repeated annual ivermectin treatment of onchocerciasis patients durably inhibited their patent\n                      <jats:italic>O<\/jats:italic>\n                      .\n                      <jats:italic>volvulus<\/jats:italic>\n                      infections despite ongoing low-level parasite transmission in the study area. Repeated MDA with ivermectin affects the expression of immunity in patients.\n                      <jats:italic>O<\/jats:italic>\n                      .\n                      <jats:italic>volvulus<\/jats:italic>\n                      parasite-specific antibody levels diminished to levels seen in infection-free endemic controls. With low antibody levels, antibody-dependent cellular cytotoxic responses against tissue-dwelling\n                      <jats:italic>O<\/jats:italic>\n                      .\n                      <jats:italic>volvulus<\/jats:italic>\n                      larvae will weaken.\n                      <jats:italic>O<\/jats:italic>\n                      .\n                      <jats:italic>volvulus<\/jats:italic>\n                      antigen inducible cytokine and chemokine production increased in treated mf-negative patients, while their innate responsiveness to mitogen declined. Such lower innate responsiveness in elderly patients could contribute to reduced adaptive immune responses to parasite infections and vaccines. On the other hand, increased specific cellular chemokine responses in mf-negative onchocerciasis patients could reflect effector cell activation against tissue invasive larval stages of\n                      <jats:italic>O<\/jats:italic>\n                      .\n                      <jats:italic>volvulus<\/jats:italic>\n                      . The annual\n                      <jats:italic>Simulium damnosum<\/jats:italic>\n                      s.l. biting rate observed in the M\u00f4 river basin was similar to levels prior to initiation of MDA with ivermectin, and the positive rtPCR results reported here confirm ongoing\n                      <jats:italic>O<\/jats:italic>\n                      .\n                      <jats:italic>volvulus<\/jats:italic>\n                      transmission.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pntd.0010340","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T13:22:23Z","timestamp":1651584143000},"page":"e0010340","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo"],"prefix":"10.1371","volume":"16","author":[{"given":"Saskia I.","family":"Johanns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"Gantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bawoubadi","family":"Wangala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kossi","family":"Komlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wemboo A.","family":"Halatoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meba","family":"Banla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Potchoziou","family":"Karabou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian JF","family":"Luty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartwig","family":"Schulz-Key","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3215-7577","authenticated-orcid":true,"given":"Peter T.","family":"Soboslay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,5,3]]},"reference":[{"key":"pntd.0010340.ref001","doi-asserted-by":"crossref","first-page":"e98411","DOI":"10.1371\/journal.pone.0098411","article-title":"Sustainable control of onchocerciasis: ocular pathology in onchocerciasis patients treated annually with ivermectin for 23 years: a cohort study.","author":"M Banla","year":"2014","journal-title":"PLoS One"},{"key":"pntd.0010340.ref002","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1365-3156.2011.02783.x","article-title":"The African Programme for Onchocerciasis Control: impact on onchocercal skin disease","volume":"16","author":"GA Ozoh","year":"2011","journal-title":"Trop Med Int Health"},{"key":"pntd.0010340.ref003","first-page":"256","article-title":"The effect of repeated doses of ivermectin on adult female Onchocerca volvulus in Sierra Leone","volume":"43","author":"DC Chavasse","year":"1992","journal-title":"Trop Med Parasitol"},{"key":"pntd.0010340.ref004","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-3156.1996.tb00083.x","article-title":"Viability and fertility of adult Onchocerca volvulus after 6 years of treatment with ivermectin","volume":"1","author":"SL Kl\u00e4ger","year":"1996","journal-title":"Trop Med Int Health"},{"key":"pntd.0010340.ref005","doi-asserted-by":"crossref","first-page":"e2824","DOI":"10.1371\/journal.pntd.0002824","article-title":"Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-na\u00efve and a frequently treated population from Cameroon.","volume":"8","author":"HC Nana-Djeunga","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0010340.ref006","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1093\/cid\/cix616","article-title":"Macrofilaricidal Efficacy of Repeated Doses of Ivermectin for the Treatment of River Blindness","volume":"65","author":"M Walker","year":"2017","journal-title":"Clin Infect Dis"},{"key":"pntd.0010340.ref007","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/infdis\/164.3.581","article-title":"Immunologic responses to repeated ivermectin treatment in patients with onchocerciasis","volume":"164","author":"C Steel","year":"1991","journal-title":"J Infect Dis"},{"key":"pntd.0010340.ref008","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0169-4758(92)90003-K","article-title":"Ivermectin-facilitated immunity.","volume":"8","author":"H Schulz-Key","year":"1992","journal-title":"Parasitol Today"},{"key":"pntd.0010340.ref009","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2249.1992.tb06971.x","article-title":"Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment","volume":"89","author":"PT Soboslay","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"pntd.0010340.ref010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1046\/j.1365-2249.1996.d01-608.x","article-title":"Ivermectin-induced immunopotentiation in onchocerciasis: recognition of selected antigens following a single dose of ivermectin","volume":"103","author":"H Akuffo","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"pntd.0010340.ref011","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-2249.2005.02910.x","article-title":"Chemokines in onchocerciasis patients after a single dose of ivermectin","volume":"142","author":"J Fendt","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"pntd.0010340.ref012","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4269\/ajtmh.1992.46.292","article-title":"Alterations in filarial antigen-specific immunologic reactivity following treatment with ivermectin and diethylcarbamazine","volume":"46","author":"PJ Lammie","year":"1992","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0010340.ref013","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2249.2006.03312.x","article-title":"Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy","volume":"147","author":"CS Mai","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"pntd.0010340.ref014","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1046\/j.1365-2567.1997.00210.x","article-title":"The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection","volume":"90","author":"PT Soboslay","year":"1997","journal-title":"Immunology"},{"key":"pntd.0010340.ref015","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.4049\/jimmunol.180.9.5771","article-title":"IL-10: the master regulator of immunity to infection","volume":"180","author":"KN Couper","year":"2008","journal-title":"J Immunol"},{"key":"pntd.0010340.ref016","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","article-title":"Regulation and functions of the IL-10 family of cytokines in inflammation and disease","volume":"29","author":"W Ouyang","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"pntd.0010340.ref017","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-3024.1995.tb00906.x","article-title":"Immunoregulation in human lymphatic filariasis: the role of interleukin 10","volume":"17","author":"S Mahanty","year":"1995","journal-title":"Parasite Immunol"},{"key":"pntd.0010340.ref018","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1365-2567.1999.00018.x","article-title":"Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls.","volume":"7","author":"PT Soboslay","year":"1999","journal-title":"Immunology"},{"key":"pntd.0010340.ref019","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/infdis\/171.3.652","article-title":"Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus","volume":"171","author":"LH Elson","year":"1995","journal-title":"J Infect Dis"},{"key":"pntd.0010340.ref020","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1128\/IAI.68.4.1905-1911.2000","article-title":"Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens","volume":"68","author":"PS Turaga","year":"2000","journal-title":"Infect Immun"},{"key":"pntd.0010340.ref021","first-page":"428","article-title":"Isolation of living adult Onchocerca volvulus from nodules","volume":"28","author":"H Schulz-Key","year":"1977","journal-title":"Tropenmed Parasitol"},{"key":"pntd.0010340.ref022","doi-asserted-by":"crossref","first-page":"e0006312","DOI":"10.1371\/journal.pntd.0006312","article-title":"Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.","volume":"12","author":"K Komlan","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0010340.ref023","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.parepi.2018.03.001","article-title":"Mansonella perstans,Onchocerca volvulus and Strongyloides stercoralis infections in rural populations in central and southern Togo.","volume":"3","author":"F Korbmacher","year":"2018","journal-title":"Parasite Epidemiol Control"},{"key":"pntd.0010340.ref024","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/infdis\/172.5.1414","article-title":"Determining the prevalence of Onchocerca volvulus infection in vector populations by polymerase chain reaction screening of pools of black flies","volume":"172","author":"CR Katholi","year":"1995","journal-title":"J Infect Dis"},{"key":"pntd.0010340.ref025","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.4049\/jimmunol.134.4.2707","article-title":"Prominence of IgG4 in the IgG antibody response to human filariasis","volume":"134","author":"EA Ottesen","year":"1985","journal-title":"J Immunol"},{"key":"pntd.0010340.ref026","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0036-1584322","article-title":"The Immunobiology of Immunoglobulin G4","volume":"36","author":"LC Lighaam","year":"2016","journal-title":"Semin Liver Dis"},{"key":"pntd.0010340.ref027","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.micinf.2011.12.002","article-title":"Chemokines and cytokines in patients with an occult Onchocerca volvulus infection","volume":"14","author":"CJ Lechner","year":"2012","journal-title":"Microbes Infect"},{"key":"pntd.0010340.ref028","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s13071-016-1623-1","article-title":"Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis.","volume":"9","author":"A Golden","year":"2016","journal-title":"Parasit Vectors"},{"key":"pntd.0010340.ref029","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/aje\/kwz109","article-title":"Predictive Value of Ov16 Antibody Prevalence in Different Subpopulations for Elimination of African Onchocerciasis","volume":"188","author":"LE Coffeng","year":"2019","journal-title":"Am J Epidemiol"},{"key":"pntd.0010340.ref030","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/infdis\/jiz307","article-title":"Integrating Multiple Biomarkers to Increase Sensitivity for the Detection of Onchocerca volvulus Infection","volume":"221","author":"S Bennuru","year":"2020","journal-title":"J Infect Dis"},{"key":"pntd.0010340.ref031","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/intimm\/12.5.623","article-title":"Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3\/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift.","volume":"2","author":"A Doetze","year":"2000","journal-title":"Int Immunol"},{"key":"pntd.0010340.ref032","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/pim.12113","article-title":"Protection and pathology during parasite infection: IL-10 strikes the balance","volume":"36","author":"SA Redpath","year":"2014","journal-title":"Parasite Immunol"},{"key":"pntd.0010340.ref033","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1086\/320709","article-title":"Early human infection with Onchocerca volvulus is associated with an enhanced parasite-specific cellular immune response","volume":"183","author":"PJ Cooper","year":"2001","journal-title":"J Infect Dis"},{"key":"pntd.0010340.ref034","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","article-title":"Cellular responses to interferon-gamma","volume":"15","author":"U Boehm","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"pntd.0010340.ref035","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.micinf.2003.11.003","article-title":"Pathogenesis and host responses in human onchocerciasis: impact of Onchocerca filariae and Wolbachia endobacteria","volume":"6","author":"NW Brattig","year":"2004","journal-title":"Microbes Infect"},{"key":"pntd.0010340.ref036","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1365-2249.1996.d01-747.x","article-title":"Immunoregulation in onchocerciasis: predominance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease","volume":"105","author":"CG L\u00fcder","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"pntd.0010340.ref037","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/pim.12113","article-title":"Protection and pathology during parasite infection: IL-10 strikes the balance","volume":"36","author":"SA Redpath","year":"2014","journal-title":"Parasite Immunol"},{"key":"pntd.0010340.ref038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1074-7613(01)00261-8","article-title":"Chemokines and the tissue-specific migration of lymphocytes","volume":"16","author":"EJ Kunkel","year":"2002","journal-title":"Immunity"},{"key":"pntd.0010340.ref039","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jdermsci.2006.06.002","article-title":"Thymus and activation regulated chemokine (TARC)\/CCL17 and skin diseases.","volume":"43","author":"H Saeki","year":"2006","journal-title":"J Dermatol Sci"},{"key":"pntd.0010340.ref040","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10787-013-0177-5","article-title":"The multiple faces of CCL13 in immunity and inflammation","volume":"21","author":"E Mendez-Enriquez","year":"2013","journal-title":"Inflammopharmacology"},{"key":"pntd.0010340.ref041","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1172\/JCI119624","article-title":"High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines","volume":"100","author":"M Uguccioni","year":"1997","journal-title":"J Clin Invest"},{"key":"pntd.0010340.ref042","doi-asserted-by":"crossref","first-page":"15036","DOI":"10.1074\/jbc.272.23.15036","article-title":"The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4","volume":"272","author":"T Imai","year":"1997","journal-title":"J Biol Chem"},{"key":"pntd.0010340.ref043","first-page":"75","article-title":"Thymus and activation regulated chemokine (TARC)\/CCL17 and skin diseases.","volume":"43","author":"H Saeki","year":"2006","journal-title":"J Dermatol"},{"key":"pntd.0010340.ref044","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/1346-8138.12440","article-title":"Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis.","volume":"41","author":"Y Kataoka","year":"2014","journal-title":"J Dermatol"},{"key":"pntd.0010340.ref045","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.micinf.2005.06.019","article-title":"Cytokine and chemokine responses in patients co-infected with Entamoeba histolytica\/dispar, Necator americanus and Mansonella perstans and changes after anti-parasite treatment","volume":"8","author":"PT Soboslay","year":"2006","journal-title":"Microbes Infect"},{"key":"pntd.0010340.ref046","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/tmi.12095","article-title":"Serum CCL11 (eotaxin-1) and CCL17 (TARC) are serological indicators of multiple helminth infections and are driven by Schistosoma mansoni infection in humans","volume":"18","author":"SM Geiger","year":"2013","journal-title":"Trop Med Int Health"},{"key":"pntd.0010340.ref047","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cyto.2018.01.023","article-title":"CCL18\u2014Beyond chemotaxis.","volume":"109","author":"C Chenivesse","year":"2018","journal-title":"Cytokine"},{"key":"pntd.0010340.ref048","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1189\/jlb.1204712","article-title":"Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes.","volume":"78","author":"E Schutyser","year":"2005","journal-title":"J Leukoc Biol"},{"issue":"3","key":"pntd.0010340.ref049","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/acel.12320","article-title":"Richner JM Global analyses revealed age-related alterations in innate immune responses after stimulation of pathogen recognition receptors","volume":"14","author":"TU Metcalf","year":"2015","journal-title":"Aging Cell"},{"issue":"2","key":"pntd.0010340.ref050","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0531-5565(98)00064-3","article-title":"Makinodan T Age-related impaired proliferation of peripheral blood mononuclear cells is associated with an increase in both IL-10 and IL-12","volume":"34","author":"SC Castle","year":"1999","journal-title":"Exp Gerontol"},{"issue":"5","key":"pntd.0010340.ref051","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.smim.2012.04.008","article-title":"Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans.","volume":"24","author":"R Solana","year":"2012","journal-title":"Semin Immunol"},{"issue":"Suppl 1","key":"pntd.0010340.ref052","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1179\/136485908X337445","article-title":"Special intervention zones.","volume":"102","author":"L Yam\u00e9ogo","year":"2008","journal-title":"Ann Trop Med Parasitol"},{"key":"pntd.0010340.ref053","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0035-9203(92)90445-I","article-title":"Seasonal variation in onchocerciasis transmission by Simulium squamosum at perennial breeding sites in Togo","volume":"86","author":"RA Cheke","year":"1992","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0010340.ref054","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4269\/ajtmh.1988.38.142","article-title":"Biting activity of black flies in Guatemala: parity rates and differences between localities and habitats","volume":"38","author":"CH Porter","year":"1988","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0010340.ref055","doi-asserted-by":"crossref","first-page":"i20","DOI":"10.1093\/inthealth\/ihx047","article-title":"Diagnostics for onchocerciasis in the era of elimination.","volume":"10","author":"TR Unnasch","year":"2018","journal-title":"Int Health"},{"key":"pntd.0010340.ref056","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1017\/S003118209700228X","article-title":"Onchocerca ochengi: epidemiological evidence of cross-protection against Onchocerca volvulus in man","volume":"116","author":"G Wahl","year":"1998","journal-title":"Parasitology"},{"key":"pntd.0010340.ref057","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1017\/S0031182099005788","article-title":"Onchocerca ochengi infections in cattle as a model for human onchocerciasis: recent developments","volume":"120","author":"AJ Trees","year":"2000","journal-title":"Parasitology"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010340","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T03:59:27Z","timestamp":1675483167000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010340"}},"subtitle":[],"editor":[{"given":"Sabine","family":"Specht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,5,3]]},"references-count":57,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0010340","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,3]]}}}